SOPHROSYNE CAPITAL LLC Information

156 EAST 36TH STREET, NEW YORK, New York, 10016, (212) 444-2500

Report Date: 06/30/2014

Position Statistics

Total Positions 93
New Positions 14
Increased Positions 30
Decreased Positions 53
Positions with Activity 83
Sold Out Positions 29
Total Mkt Value (in $ millions) 99

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials 3.49%
Capital Goods 5.56%
Conglomerates 0%
Consumer Cyclical 0.12%
Consumer/Non-Cyclical 2.56%
Energy 0.41%
Financial 7.24%
Healthcare 40.41%
Services 4.93%
Technology 23.77%
Transportation 0.23%
Utilities 2.82%

93 Positions as of 06/30/2014

Company Class Value of Shares ($1,000s) Change in Value ($1,000s) Change (%) ▲ Shares Held
8X8 INC NEW COM -313 Sold Out 0
ACELRX PHARMACEUTICALS INC COM -1,773 Sold Out 0
ACORN ENERGY INC COM -589 Sold Out 0
ASTERIAS BIOTHERAPEUTICS INC COM SER A -18 Sold Out 0
CUTERA INC COM -1,348 Sold Out 0
DURATA THERAPEUTICS INC COM -1,637 Sold Out 0
EDWARDS LIFESCIENCES CORP COM -688 Sold Out 0
FIVE PRIME THERAPEUTICS INC COM -257 Sold Out 0
GERON CORP COM -328 Sold Out 0
HANGER INC COM NEW -581 Sold Out 0
INSPIREMD INC COM NEW -388 Sold Out 0
LINDSAY CORP COM -132 Sold Out 0
NATURAL GAS SERVICES GROUP COM -209 Sold Out 0
NEKTAR THERAPEUTICS COM -861 Sold Out 0
NET 1 UEPS TECHNOLOGIES INC COM NEW -4,463 Sold Out 0
OCULUS INNOVATIVE SCIENCES INC COM NEW -349 Sold Out 0
OMEGA PROTEIN CORP COM -57 Sold Out 0
PHARMATHENE INC COM -399 Sold Out 0
PICO HLDGS INC COM NEW -278 Sold Out 0
QUALYS INC COM -257 Sold Out 0